Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Widepoint (WYY) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Widepoint (WYY) over the last 13 years, with Q3 2025 value amounting to $7413.0.

  • Widepoint's Asset Writedowns and Impairment fell 567.5% to $7413.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $38928.0, marking a year-over-year decrease of 7774.79%. This contributed to the annual value of $21818.0 for FY2024, which is 8871.5% down from last year.
  • Per Widepoint's latest filing, its Asset Writedowns and Impairment stood at $7413.0 for Q3 2025, which was down 567.5% from $24505.0 recorded in Q2 2025.
  • Widepoint's Asset Writedowns and Impairment's 5-year high stood at $16.3 million during Q2 2022, with a 5-year trough of -$16.3 million in Q4 2022.
  • For the 5-year period, Widepoint's Asset Writedowns and Impairment averaged around $18134.1, with its median value being $7094.5 (2025).
  • The largest annual percentage gain for Widepoint's Asset Writedowns and Impairment in the last 5 years was 6698719.95% (2022), contrasted with its biggest fall of 3330163.3% (2022).
  • Over the past 5 years, Widepoint's Asset Writedowns and Impairment (Quarter) stood at $48989.0 in 2021, then tumbled by 33301.63% to -$16.3 million in 2022, then soared by 100.94% to $153357.0 in 2023, then tumbled by 99.85% to $234.0 in 2024, then skyrocketed by 3067.95% to $7413.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $7413.0 for Q3 2025, versus $24505.0 for Q2 2025 and $6776.0 for Q1 2025.